Skip to main content

Table 3 Secondary outcomes

From: Effects of prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge on interleukin-6 concentration in patients with septic shock: a prospective exploratory trial

  PMX-DHP-2 h (n = 7) PMX-DHP-12 h
(n = 16)
P value
ICU-free days at day 28, median (IQR) 22 (18–23) 18 (2–24) 0.36
Vasopressor-free days at day 28, median (IQR) 18 (16–25) 21 (5–24) 0.97
RRT-free days at day 28, median (IQR)* 28 (8–28) 20 (26–28) 0.19
Ventilator-free days at day 28, median (IQR) 23 (13–24) 18 (0–25) 0.57
ICU mortality, number (%) 1 (14%) 3 (19%) 1.00
Hospital mortality, number (%) 1 (14%) 7 (44%) 0.35
  1. PMX-DHP-2h polymyxin direct hemoperfusion for 2 h, PMX-DHP-12h polymyxin direct hemoperfusion for 12 h, ICU intensive care unit, RRT renal replacement therapy, IQR interquartile range
  2. *RRT-free days were compared between groups after excluding patients undergoing chronic dialysis